Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Approvals/Philippines FDA/Acuvis

Approved

STANDARD

Acuvis

Daewoo Pharm. Co.🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: 9c79465824433b20
Company: Daewoo Pharm. Co.
Type: Standard

Approval Details

Approval Id: 9c79465824433b20
Drug Approval Philippines Name: Acuvis
Product Name: Acuvis
Registration Number: DRP-7680-02
Brand Name: Acuvis
Generic Name: Sodium Hyaluronate
Dosage Form: Ophthalmic Solution (Eye Drops)
Dosage Strength: 1mg/mL (0.1% w/v)
Manufacturer: Daewoo Pharm. Co.
Importer: Bliss Pharma Distribution And Consultancy Corp
Distributor: Avantmed International Pharma, inc.
Issuance Date: 28 September 2024
Expiry Date: 16 December 2029
Pharmacologic Category: Ocular Lubricant
Classification: Prescription Drug (RX)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

9c79465824433b20

Type

Standard

Back to Philippines FDA Approvals

Acuvis - Philippines FDA Drug Approval Details